Groupe d'Etude en Oncologie du Quebec

Titre	A Phase 1/1b First-in-human Study of BMS-986463 in Advanced Malignant Tumors
Protocole ID	CA231-0000
ClinicalTrials.gov ID	NCT06476808
Type(s) de cancer	Ovaire Utérus (sarcome)
Phase	Phase I
Type étude	Clinique
Médicament	BMS-986463
Institution	CIUSSS DU CENTRE-OUEST-DE-L'ILE-DE-MONTREAL HOPITAL GENERAL JUIF SIR MORTIMER B.DAVIS 3755 rue de la Côte Ste. Catherine, Montréal, QC, H3T 1E2
Ville	Montréal
Investigateur(trice) principal(e)	Dre Susie Lau
Coordonnateur(trice)	Alessandra Figueiredo De Vasconcelos 514-340-8222 poste 26823
Statut	Actif en recrutement
Critètes d'éligibilité	Participants must have an Eastern Cooperative Oncology Group Performance Status of 0 or 1. Participants must have at least 1 lesion accessible for biopsy in addition to the target lesion, from which a fresh pre treatment biopsy must be obtained. Participants must have an unresectable/metastatic carcinoma.
Critètes d'exclusion	Participants must not have Leptomeningeal metastases. Participants must not have concurrent malignancy (present during screening) requiring treatment or history of prior malignancy active within 2 years prior to treatment. Participants must not have had any prior radiation therapy within 2 weeks prior to start of study treatment. Other protocol-defined Inclusion/Exclusion criteria apply.

Groupe d'étude en oncologie du Québec